New England Journal of Medicine Q1 Unclaimed
The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community. Our mission is to bring physicians the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable and clinically useful formats It has an SJR impact factor of 24.907.
New England Journal of Medicine focuses its scope in these topics and keywords: patients, treatment, care, therapy, virus, chronic, medical, trial, coronary, primary, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
0 €
Inmediate OA- €
Embargoed OA- €
Non OAMetrics
24.907
SJR Impact factor1079
H Index1453
Total Docs (Last Year)4498
Total Docs (3 years)14767
Total Refs143343
Total Cites (3 years)1891
Citable Docs (3 years)35.41
Cites/Doc (2 years)10.16
Ref/DocOther journals with similar parameters
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
Psychological science in the public interest : a journal of the American Psychological Society Q1
Accounts of Chemical Research Q1
Compare this journals
Aims and Scope
Best articles by citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
16907 Citations View moreClinical Characteristics of Coronavirus Disease 2019 in China
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
11973 Citations View moreImproved Survival with Ipilimumab in Patients with Metastatic Melanoma
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Sorafenib in Advanced Hepatocellular Carcinoma
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
7971 Citations View moreUse of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Intensive Insulin Therapy in Critically Ill Patients
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
6153 Citations View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments